(Q36204361)

12 August 2017

A phase II study of oral etoposide in elderly patients with small cell lung cancer (English)

1 reference

12 August 2017

1 reference

1 reference

5

Postmus PE

1 reference

12 August 2017

Smit EF

1

1 reference

12 August 2017

Carney DN

series ordinal

2

1 reference

12 August 2017

Harford P

series ordinal

3

1 reference

12 August 2017

Sleijfer DT

series ordinal

4

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 August 1989

1 reference

12 August 2017

1 reference

12 August 2017

44

1 reference

12 August 2017

631-633

1 reference

12 August 2017

8

1 reference

Current status of therapy for small cell carcinoma of the lung

12 August 2017

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=461991

Small cell carcinoma of the lung: influence of age on treatment outcome

1 October 2017

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=461991

Bioavailability, pharmacokinetics, and clinical effects of an oral preparation of etoposide

2 July 2018

1 reference

12 December 2020

Choice of cancer therapy varies with age of patient

1 reference

12 December 2020

Phase II trial of vindesine and VP16-213 in the palliation of poor-prognosis patients and elderly patients with small cell lung cancer

1 reference

12 December 2020

Lung carcinoma in the elderly population. Influence of histology on the inverse relationship of stage to age

1 reference

12 December 2020

Vincristine and etoposide: an effective chemotherapy regimen with reduced toxicity in extensive small-cell lung cancer

1 reference

12 December 2020

Identifiers

DOI

10.1136/THX.44.8.631

1 reference

12 August 2017

1 reference

12 August 2017

1 reference